Analysts’ Recent Ratings Updates for Corteva (CTVA)

Several analysts have recently updated their ratings and price targets for Corteva (NYSE: CTVA):

• 4/16/2024 – Corteva had its price target raised by analysts at Oppenheimer Holdings Inc. from $62.00 to $67.00. They now have an “outperform” rating on the stock.
• 4/12/2024 – Corteva had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $57.00 price target on the stock, down previously from $58.00.
• 4/10/2024 – Corteva had its price target raised by analysts at Barclays PLC from $55.00 to $58.00. They now have an “equal weight” rating on the stock.
• 4/9/2024 – Corteva had its price target raised by analysts at KeyCorp from $63.00 to $66.00. They now have an “overweight” rating on the stock.
• 3/1/2024 – Corteva is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $67.00 price target on the stock.
• 2/27/2024 – Corteva was upgraded by analysts at TheStreet from a “c+” rating to a “b-” rating.

Corteva Stock Performance

Shares of CTVA opened at $54.70 on Friday. The company has a 50-day simple moving average of $55.28 and a 200-day simple moving average of $50.43. The company has a quick ratio of 0.90, a current ratio of 1.56 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $38.23 billion, a PE ratio of 53.63, a P/E/G ratio of 1.45 and a beta of 0.77. Corteva, Inc. has a 52-week low of $43.22 and a 52-week high of $61.87.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Thursday, February 1st. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.09. The business had revenue of $3.71 billion during the quarter, compared to the consensus estimate of $3.54 billion. Corteva had a net margin of 4.27% and a return on equity of 7.43%. During the same quarter last year, the firm posted $0.16 EPS. Equities research analysts predict that Corteva, Inc. will post 2.84 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Corteva

Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in shares of Corteva by 2.4% during the 3rd quarter. Vanguard Group Inc. now owns 81,346,924 shares of the company’s stock worth $4,161,709,000 after purchasing an additional 1,941,323 shares during the last quarter. Capital International Investors boosted its stake in shares of Corteva by 47.2% during the 4th quarter. Capital International Investors now owns 25,758,735 shares of the company’s stock worth $1,234,359,000 after purchasing an additional 8,260,808 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Corteva by 19.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 13,236,504 shares of the company’s stock worth $634,293,000 after purchasing an additional 2,141,428 shares during the last quarter. Northern Trust Corp boosted its stake in shares of Corteva by 2.5% during the 4th quarter. Northern Trust Corp now owns 12,815,795 shares of the company’s stock worth $614,133,000 after purchasing an additional 310,012 shares during the last quarter. Finally, Harris Associates L P boosted its stake in shares of Corteva by 87.1% during the 4th quarter. Harris Associates L P now owns 9,011,702 shares of the company’s stock worth $431,841,000 after purchasing an additional 4,194,981 shares during the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.